NovaCell Technology Overview
- Founded
-
2000
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$9.1M
- Investors
-
4
NovaCell Technology General Information
Description
Developer of biomaterials and pharmaceuticals intended to balance the immune system in a healthy way. The company's provides contract research services for new drug development as well as conducting collaborative research products with various other domestic and foreign universities, research labs and institutions, enabling patients to cure diseases, such as atopy, asthma, dry eye disease, and inflammatory bowel disease.
Contact Information
Website
www.novacelltech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
- 77, Cheongam-ro, Nam-gu
- Pohang University of Science and Technology
- Pohang-si, Gyeongsangbuk-do
- South Korea
+82 000-000-0000
NovaCell Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | $9.1M | 000.00 | Completed | Generating Revenue | ||
| 1. Later Stage VC | 28-Sep-2020 | 00.000 | 00.000 | Completed | Generating Revenue |
NovaCell Technology Patents
NovaCell Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2020152723-A | Novel multi-functional peptides and use thereof | Pending | 19-Mar-2019 | 000000000 | |
| US-20200405802-A1 | Novel multi-functional peptides and use thereof | Pending | 19-Mar-2019 | 000000000 | |
| EP-3711745-A3 | Novel multi-functional peptides and use thereof | Pending | 19-Mar-2019 | 000000000 | 0 |
| EP-3711745-A2 | Novel multi-functional peptides and use thereof | Pending | 19-Mar-2019 | 000000000 | 0 |
| US-10421781-B2 | Antimicrobial peptide and use thereof | Active | 18-Nov-2015 | C07K7/06 | 0 |
NovaCell Technology Executive Team (5)
NovaCell Technology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| AION Partners (New York) | Real Estate | Minority | 000 0000 | 000000 0 | |
| Huons Global | Corporation | Minority | 000 0000 | 000000 0 | |
| Korea Investment Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Quantum Ventures Korea | Venture Capital | Minority | 000 0000 | 000000 0 |